BR9916046A - Composto, composição farmacêutica, e, processos para inibir a replicação de um vìrus herpes e para tratamento de um paciente que sofra de uma infecção do vìrus herpes - Google Patents
Composto, composição farmacêutica, e, processos para inibir a replicação de um vìrus herpes e para tratamento de um paciente que sofra de uma infecção do vìrus herpesInfo
- Publication number
- BR9916046A BR9916046A BR9916046-3A BR9916046A BR9916046A BR 9916046 A BR9916046 A BR 9916046A BR 9916046 A BR9916046 A BR 9916046A BR 9916046 A BR9916046 A BR 9916046A
- Authority
- BR
- Brazil
- Prior art keywords
- carbon atoms
- alkyl
- herpes virus
- hydrogen
- heteroaryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
Abstract
"COMPOSTO, COMPOSIçãO FARMACêUTICA, E, PROCESSOS PARA INIBIR A REPLICAçãO DE UM VìRUS HERPES E PARA TRATAMENTO DE UM PACIENTE QUE SOFRA DE UMA INFECçãO DO VìRUS HERPES" Os compostos tendo a fórmula (I), em que R~ 1~ a R~ 5~ são independentemente selecionados de hidrogênio, alquila de 1 a 6 átomos de carbono, alquenila de 2 a 6 átomos de carbono, alquinila de 2 a 6 átomos de carbono, per-haloalquila de 1 a 6 átomos de carbono, cicloalquila de 3 a 10 átomos de carbono, heterocicloalquila de 3 a 10 membros de carbono, arila, heteroarila, halogênio, CN, NO~ 2~, CO~ 2~R~ 6~, COR~ 6~, OR~ 6~, SR~ 6~, SOR~ 6~, SO~ 2~R~ 6~, CON~ 7~R~ 8~, NR~ 6~N(R~ 7~R~ 8~), N(R~ 7~R~ 8~) ou W-Y-(CH~ 2~)~ n~-Z, contanto que pelo menos um dentre R~ 1~ a R~ 5~ não seja hidrogênio; ou R~ 2~ e R~ 3~, ou R~ 3~ e R~ 4~, tomados juntos, formem uma heterocicloalquila de 3 a 7 membros, ou heteroarila de 3 a 7 membros; R~ 6~ e R~ 7~ são independentemente hidrogênio, alquila de 1 a 6 átomos de carbono, per-haloalquila de 1 a 6 átomos de carbono, ou arila; R~ 8~ é hidrogênio, alquila de 1 a 6 átomos de carbono, per-haloalquila de 1 a 6 átomos de carbono, cicloalquila de 3 a 10 átomos de carbono, heterocicloalquila de 3 a 10 membros, arila ou heteroarila, ou R^ 7^ e R^ 8^ tomados juntos podem formar uma heterocicloalquila de 3 a 7 membros; W é O, NR~ 6~, ou está ausente; Y é (CO)- ou (CO~ 2~)-, ou está ausente; Z é alquila de 1 a 4 átomos de carbono, CN, CO~ 2~R~ 6~, COR~ 6~, CONR~ 7~R~ 8~, OCOR~ 6~, NR~ 6~COR~ 7~, OCONR~ 6~, OR~ 6~, SR~ 6~, SOR~ 6~, SO~ 2~R~ 6~, SR~ 6~N(R~ 7~R~ 8~), N(R~ 7~R~ 8~) ou fenila; G é heteroarila monocíclica; X é uma ligação, NH, alquila de 1 a 6 átomos de carbono, alquenila de 1 a 6 átomos de carbono, alcóxi de 1 a 6 átomos de carbono, ou tioalquila de 1 a 6 átomos de carbono, alquilamino de 1 a 6 átomos de carbono,, ou (CH)J; J é alquila de 1 a 6 átomos de carbono, cicloalquila de 3 a 7 átomos de carbono, fenila ou benzila; e n é um número inteiro de 1 a 6, útil no tratamento de doenças associadas com os vírus herpes, incluindo o citomegalovírus humano, o vírus do herpes simplex, o vírus Epstein-Barr, o vírus varicela-zoster, o herpesvírus 6 e 7, e o herpesvírus de Kaposi.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20855998A | 1998-12-09 | 1998-12-09 | |
| PCT/US1999/028842 WO2000034258A2 (en) | 1998-12-09 | 1999-12-06 | Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9916046A true BR9916046A (pt) | 2001-10-02 |
Family
ID=22775044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9916046-3A BR9916046A (pt) | 1998-12-09 | 1999-12-06 | Composto, composição farmacêutica, e, processos para inibir a replicação de um vìrus herpes e para tratamento de um paciente que sofra de uma infecção do vìrus herpes |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1144397A3 (pt) |
| JP (1) | JP2002531554A (pt) |
| CN (1) | CN1348446A (pt) |
| AU (1) | AU1934700A (pt) |
| BG (1) | BG105581A (pt) |
| BR (1) | BR9916046A (pt) |
| CA (1) | CA2350767A1 (pt) |
| CZ (1) | CZ20011956A3 (pt) |
| EA (1) | EA200100631A1 (pt) |
| HU (1) | HUP0200232A2 (pt) |
| ID (1) | ID30158A (pt) |
| IL (1) | IL143182A0 (pt) |
| NO (1) | NO20012832L (pt) |
| PL (1) | PL349217A1 (pt) |
| SK (1) | SK7682001A3 (pt) |
| TR (1) | TR200101664T2 (pt) |
| WO (1) | WO2000034258A2 (pt) |
| ZA (1) | ZA200104377B (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6166028A (en) * | 1998-12-09 | 2000-12-26 | American Home Products Corporation | Diaminopuridine-containing thiourea inhibitors of herpes viruses |
| US6844367B1 (en) | 1999-09-17 | 2005-01-18 | Millennium Pharmaceuticals, Inc. | Benzamides and related inhibitors of factor Xa |
| DK1259485T3 (da) | 2000-02-29 | 2006-04-10 | Millennium Pharm Inc | Benzamider og beslægtede inhibitorer for faktor Xa |
| US7220768B2 (en) * | 2003-02-11 | 2007-05-22 | Wyeth Holdings Corp. | Isoxazole-containing thiourea inhibitors useful for treatment of varicella zoster virus |
| ES2382055T3 (es) | 2006-11-02 | 2012-06-04 | Millennium Pharmaceuticals, Inc. | Métodos para sintetizar sales farmacéuticas de un inhibidor del factor Xa |
| WO2014070979A1 (en) * | 2012-11-03 | 2014-05-08 | Boehringer Ingelheim International Gmbh | Inhibitors of cytomegalovirus |
| EP2914591B1 (en) * | 2012-11-03 | 2017-10-11 | Boehringer Ingelheim International GmbH | Inhibitors of cytomegalovirus |
| CN110565100B (zh) * | 2019-07-12 | 2021-05-07 | 西北工业大学 | 一种二茂钴阳离子基缓蚀剂及制备方法和使用方法 |
| CN117769548A (zh) | 2021-08-05 | 2024-03-26 | 浙江海正药业股份有限公司 | 芳香乙炔类衍生物及其制备方法和用途 |
| WO2023088718A1 (en) | 2021-11-19 | 2023-05-25 | Basf Se | Bicyclic compounds for the control of invertebrate pests |
| CN115433093A (zh) * | 2022-09-26 | 2022-12-06 | 无锡双启科技有限公司 | 一种3-氯-4-三氟甲基苯胺的制备方法 |
| CN115710190A (zh) * | 2022-11-16 | 2023-02-24 | 常州佳德医药科技有限公司 | 4-甲氧基-2-氨基-n,n-二甲基苯胺、制备方法及应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69811062T2 (de) * | 1997-04-10 | 2003-07-17 | Upjohn Co | Polyaromatische antivirale zusammensetzungen |
-
1999
- 1999-12-06 WO PCT/US1999/028842 patent/WO2000034258A2/en not_active Application Discontinuation
- 1999-12-06 BR BR9916046-3A patent/BR9916046A/pt not_active Application Discontinuation
- 1999-12-06 SK SK768-2001A patent/SK7682001A3/sk unknown
- 1999-12-06 IL IL14318299A patent/IL143182A0/xx unknown
- 1999-12-06 AU AU19347/00A patent/AU1934700A/en not_active Abandoned
- 1999-12-06 ID IDW00200101231A patent/ID30158A/id unknown
- 1999-12-06 JP JP2000586705A patent/JP2002531554A/ja active Pending
- 1999-12-06 EA EA200100631A patent/EA200100631A1/ru unknown
- 1999-12-06 EP EP99963023A patent/EP1144397A3/en not_active Withdrawn
- 1999-12-06 CN CN99815997A patent/CN1348446A/zh active Pending
- 1999-12-06 TR TR2001/01664T patent/TR200101664T2/xx unknown
- 1999-12-06 CZ CZ20011956A patent/CZ20011956A3/cs unknown
- 1999-12-06 HU HU0200232A patent/HUP0200232A2/hu unknown
- 1999-12-06 PL PL99349217A patent/PL349217A1/xx not_active Application Discontinuation
- 1999-12-06 CA CA002350767A patent/CA2350767A1/en not_active Abandoned
-
2001
- 2001-05-28 ZA ZA200104377A patent/ZA200104377B/en unknown
- 2001-06-08 BG BG105581A patent/BG105581A/xx unknown
- 2001-06-08 NO NO20012832A patent/NO20012832L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU1934700A (en) | 2000-06-26 |
| CN1348446A (zh) | 2002-05-08 |
| PL349217A1 (en) | 2002-07-01 |
| EP1144397A3 (en) | 2002-09-11 |
| ZA200104377B (en) | 2002-12-20 |
| ID30158A (id) | 2001-11-08 |
| NO20012832D0 (no) | 2001-06-08 |
| SK7682001A3 (en) | 2002-07-02 |
| EP1144397A2 (en) | 2001-10-17 |
| CA2350767A1 (en) | 2000-06-15 |
| IL143182A0 (en) | 2002-04-21 |
| BG105581A (en) | 2001-12-31 |
| NO20012832L (no) | 2001-08-07 |
| EA200100631A1 (ru) | 2002-02-28 |
| CZ20011956A3 (cs) | 2001-10-17 |
| JP2002531554A (ja) | 2002-09-24 |
| WO2000034258A2 (en) | 2000-06-15 |
| HUP0200232A2 (hu) | 2002-05-29 |
| TR200101664T2 (tr) | 2002-03-21 |
| WO2000034258A3 (en) | 2001-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1998056761A3 (en) | Benzimidazole derivatives | |
| BR9812046A (pt) | Compostos, processos para a preperação do composto e para tratar um paciente humano ou animal, composição farmacêutica, e, uso de um composto | |
| MY117892A (en) | Therapeutic compounds | |
| ES2080297T3 (es) | Derivados 17-g(b)-sustituido-4-aza-5g(a)-androstan-3-ona y procedimiento de preparacion de estos. | |
| BR9916046A (pt) | Composto, composição farmacêutica, e, processos para inibir a replicação de um vìrus herpes e para tratamento de um paciente que sofra de uma infecção do vìrus herpes | |
| EP0139534A3 (en) | Compositions for the prophylactic treatment of osteitis and osteomyelitis | |
| PT915894E (pt) | Analogos de nucleotidos | |
| BR9916041A (pt) | Composto, composição farmacêutica, e, métodospara inibir a replicação de um vìrus do herpes epara tratar um paciente sofrendo de uma infecçãopor vìrus do herpes | |
| NZ324380A (en) | Therapeutic benzimidazole compounds and their use in treatment of virus infections | |
| BR9916086A (pt) | Composto, composição farmacêutica, método para inibir a replicação de um vìrus do herpes, método para tratar um paciente sofrendo de uma infecção por vìrus do herpes | |
| WO2000034261A3 (en) | Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group | |
| DE69232417T2 (de) | Michellamine zur verwendung als antivirale wirkstoffe, zusammensetzung und behandlungsverfahren | |
| BR9916084A (pt) | Composto, composição farmacêutica, e, processos para inibir a replicação de um vìrus da herpes, e para tratar um paciente sofrendo de uma infecção por vìrus da herpes | |
| BR9916042A (pt) | Composto, composição farmacêutica, e, processospara inibir a replicação de um vìrus herpes, e detratamento de um paciente que sofra de umainfecção do vìrus herpes | |
| BR9915993A (pt) | Composto, composição farmacêutica, processo para inibir a replicação de um vìrus herpes, e, processo para tratar um paciente sofrendo de uma infecção de vìrus herpes | |
| ES8604843A1 (es) | Un metodo para la preparacion de un derivado de acetileno | |
| DE69014337D1 (de) | Verwendung von 5-Alkylpyridazin-Derivaten als Medikamente zur Beeinflussung des cholinergen Systems. | |
| NO893279L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-amino-4-morfolino-6-propyl-1,3,5-triaziner. | |
| EA199801012A1 (ru) | Производные полигидроксифенола, содержащие их лекарственные композиции и применение указанных веществ для профилактики и лечения заболеваний костей и хрящей | |
| DE69511247D1 (de) | Therapeutische benzonitrile |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |